L-Theanine

L-theanine is a non-protein amino acid concentrated in the leaves of Camellia sinensis, the tea plant. It crosses the blood-brain barrier and is sold as a stand-alone capsule and as a caffeine pairing, marketed for calm focus.

The best current summary of the evidence is a 2026 systematic review and meta-analysis of 31 randomized controlled trials (n=1,168) comparing oral L-theanine with placebo. It found that a single 200 mg dose taken 30-60 minutes before cognitive testing significantly improved choice reaction time (standardized mean difference 0.51, 95% CI 0.25-0.77), a real and replicated attention effect [1]. The same meta-analysis found the reduction in acute subjective stress was smaller (SMD 0.31) and, importantly, was largely driven by studies at high risk of bias, a signal the authors flagged rather than hid. A separate four-week randomized, placebo-controlled crossover trial in 30 healthy adults (200 mg/day) reported improved verbal fluency (p=0.001) and executive function (p=0.031) scores after theanine versus placebo, alongside reductions in self-reported depression, anxiety, and sleep-disturbance scores [2].

What the evidence does not show: L-theanine has not been shown to treat clinical anxiety. A double-blind, randomized, placebo-controlled trial of 46 patients with a formal DSM-5 diagnosis of generalized anxiety disorder, using adjunctive L-theanine at 450-900 mg/day on top of stable antidepressant treatment for 8 weeks, found that L-theanine did not outperform placebo on the Hamilton Anxiety Rating Scale (p=0.73) [3]. That is a real, clean null result in a clinical population. It is not a case of an underpowered trial finding nothing: it directly tested the strongest version of the anxiety claim and it failed. The attention benefit, meanwhile, is well established only for single, acute 200 mg doses in healthy people performing lab-based reaction-time tasks; it says nothing about chronic anxiety, mood disorders, or long-term cognitive change, and standalone (non-caffeine) chronic dosing trials for broader cognition have produced mixed, mostly non-significant results.

Blueprint lists L-theanine, alongside magnesium and glycine, as one of the ingredients in its Longevity Mix supplement blend, framed there as supporting sleep and recovery [4]. This is Bryan Johnson's own product formulation choice, an n=1 self-report and commercial framing, not a controlled trial result, and should not be read as independent evidence that the combination improves sleep in a general population.

Critics of theanine marketing point out that the anxiety claim commonly advertised to consumers is built almost entirely on acute-stress paradigms in healthy volunteers under laboratory stressors, a very different situation from someone with a diagnosed anxiety disorder, and that the one RCT that tested the clinical-anxiety claim directly returned a null result (p=0.73) [3].

The honest takeaway: a single 200 mg dose of L-theanine produces a small, real improvement in reaction time and attention in healthy adults. It has not been shown to treat generalized anxiety disorder in a clinical trial that tested exactly that claim.

Products with this: L-Theanine